Laboratory diagnosis of invasive aspergillosis;El diagnóstico de laboratorio de la aspergilosis invasora

Revista Iberoamericana de Micologia

Volumn 20, Issue 3, 2003, Pages 90-98

  Del Palacio, Amalia ^a   Cuétara, María Soledad ^b   Pontón, José ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Diagnostic methods; Invasive aspergillosis

Indexed keywords

FUNGAL DNA; GALACTOMANNAN;

ANTIGEN DETECTION; ASPERGILLOSIS; ASPERGILLUS; BLOOD CULTURE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FUNGUS CULTURE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNE DEFICIENCY; LABORATORY DIAGNOSIS; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS;

ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; DNA, FUNGAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; MANNANS; MYCOLOGY; NEOPLASMS; NEUTROPENIA; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ASPERGILLUS; FUNGI;

EID: 0345871001     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Abarca ML. Taxonomia e identificación de especies implicadas en la aspergilosis nosocomial. Rev Iberoam Micol 2000; 17: S79-S84.
2. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
3. Borges M, Liébana A. Presentaciones clínicas de la aspergilosis nosocomial. Rev Iberoam Micol 2000; 17: S85-S89.
4. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-805.
5. Paterson D, Singh N. Invasive aspergillosis in transplant recipients. Medicine 1999; 78: 123-138.
6. Lin SJ, Schanz J, Teutsch SM. Aspergillosis case fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-366.
7. Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, risk based, antifungal strategy in neutropenic patients. Br J Haematol 2000; 110: 273-284.
8. Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 1997; 64: 716-720.
9. Singh N. Trends in the epidemiology of opportunistic fungal infections; predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis 2001; 33: 1692-1696.
10. rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, 2003.
11. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices and outcomes. Medicine 2000; 79: 250-260.
12. Groll AH, Shah PM, Mentzel C, et al. Trends in the post-mortem epidemiology of invasive fungal ifections at a University hospital. J Infect 1996; 33: 23-32.
13. Vogesen M, Wanders A, Haas A, Ruckdeschel G. A four-year review of fatal aspergillosis. Eur J Clin Microbiol Infect Dis 1999; 18: 42-45.
14. Denning DW. Early diagnosis of invasive aspergillosis. Lancet 2000; 355: 423-424.
15. Von Eiff M, Zuhlsdorf M, Roos N, et al. Pulmonary fungal infections in patients with haematological malignancies-diagnostic approaches. Ann Hematol 1995; 70: 135-141.
16. Binder C, Ruchel R. Mixed systemic mycosis with fatal outcome in a patient with acute myeloblastic leukaemia. Mycoses 2000; 43: 59-63.
17. Pontón J, García ME, López Medrano R. Diagnóstico basado en métodos independientes del cultivo. En: Pemán J, Martín Mazuelos E, Rubio MC (Eds.) Guía práctica de identificación y diagnóstico en Micología Clínica. Bilbao, Revista Iberoamericana de Micología, 2001: 14.1-14.21.
18. Pemán J. Diagnóstico de la aspergilosis invasiva. Rev Iberoam Micol 2000; 17: S90-S92.
19. Barnes AJ, Denning DW. Aspergillii-significance as pathogens. Rev Med Microbiol 1993; 4: 176-180.
20. Horvath JA, Dummer S. The use of respiratory - tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171-178.
21. Mc Whinney PH, Kibbler CC, Hamon MD, et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years'experience. Clin Infect Dis 1993; 17: 397-404.
22. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: results from a three-year prospective study. Am J Med 1986; 81: 249-254.
23. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33: 1824-1833.
24. Jantunen E, Piilonin A, Volin L, et al. Diagnostic aspects of invasive Aspergillus infection in allogenic BMT recipients. Bone Marrow Transpl 2000; 25: 867-871.
25. Ascioglu S, de Paw B, Bennett JE, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
26. Wheeler MS, Mc Ginnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol 1981; 75: 304-311.
27. Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin Infect Dis 1995; 20: 598-605.
28. Kontoyiannis DP, Sumoza D, Tarrand J, et al. Significance of aspergillemia in patients with cancer: a 10 year study. Clin Infect Dis 2000; 31: 188-189.
29. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-1906.
30. Chan C, Woo PCY, Llung ASP, et al. Detection of antibodies specific to an antigenic all wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis. J Clin Microbiol 2002; 40: 2041-2045.
31. Obayashi T, Yoshida M, Mori T, et al. Plasma (1-3)-β-D glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17-20.
32. Verweig PE, Erjavec Z, Sluiters W, et al. Detection of antigen in sera of patients with invasive aspergillosis: intra-and interlaboratory reproducibility. J Clin Microbiol 1998; 36: 1612-1616.
33. Maertens J, Verhaegen J, Demuynck H, et al. Autopsy - controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunoabsorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microb 1999; 37: 3223-3228.
34. Maertens J, Verhaegen J, Lagrou K, et al. Screening for circulating galactomannan as a non-invasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97; 1604-1610.
35. Sulahian A, Boutboul, Ribaud P, et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4 year prospective study. Cancer 2001; 91: 311-318.
36. Siemann N, Koch-Dorfler M, Gaude M. False positive results in premature infants with the Platelia® Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 1998; 41: 373-377.
37. Maertens J, Van Eldere J, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogenic stem cell transplant recipients. J Infect Dis 2002; 186: 1297-1306.
38. Mc Laughlin L, Balajee A, Leisenring W, et al. Bio-Rad Platelia® Aspergillus EIA detection of Aspergillus galactomannan antigen in human serum: performance evaluation in a large bone marrow transplant center, Poster 7. Focus on Fungal Infections. Phoenix, Arizona, March 20-22, 2002.
39. Boutboul F, Alberti C, Leblanc T, et al. Invasive aspergilosis in allogenic stem cell transplant recipients: increasing antigemia is associated with progressive disease. Clin Infect Dis 2002; 34: 939-943.
40. Patterson TF, Miniter P, Ryan JL, Andriole VT. Effect of immunosuppresion and amphotericin B on Aspergillus antigenemia in an experimental model. J Infect Dis 1988; 158: 415-422.
41. Petraitiene R, Petraitis VV, Groll AH, et al. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother 2001; 45: 857-869.
42. Fortún J, Martín Dávila P, Alvarez M, et al. Aspergillus antigenemia sándwich-enzyme immunoassay test as a sero-diagnostic meted for invasive aspergillosis in liver transplant recipients. Transplantation 2001; 71: 145-149.
43. Klont RR, Meis JFG, Verweij PE. Critical assessment of issues in the diagnosis of invasive aspergillosis. Clin Microbiol Infect 2001; 7 (Supplement 2): 32-37.
44. Verweij PE, Weemaes CM, Curfs Jo HAJ, et al. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 2000; 38: 3900-3901.
45. Swanink CM, Meis JF, Rijs AJ, et al. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257-260.
46. Kami M, Kanda Y, Ogawa S, et al. Frequent false-positive results of Aspergillus latex agglutination test: transient Aspergillus antigenemia during neutropenia. Cancer 1999; 86: 274-281.
47. Hamaki T, Kami M, Kanda Y, et al. False-positive results of Aspergillus enzyme-linked immunosorbent assay in a patient with chronic graft - versus - host disease after allogenic bone marrow transplantation. Bone Marrow Transplant 2001; 28: 633-634.
48. Gangneux JP, Lavarde D, Bretagne S, et al. Transient Aspergillus antigenemia: think of milk. Lancet 2002; 359: 1251.
49. Ansorg R, van de Boom R, Rath PM. Detection of Aspergillus galacomannan antigen in foods and antibiotics. Mycoses 1997; 40: 353-357.
50. Patterson TF, Minter P, Patterson JE, et al. Aspergillus antigen detection in the diagnosis of invasive aspergillosis. J Infect Dis 1995; 171: 1553-1558.
51. Severens JL, Donnelly JP, Meis JF, et al. Two strategies for managing invasive aspergillosis: a decision analysis. Clin Infect Dis 1997; 25: 1148-1154.
52. Caillot D, Casanovas O, Bernard A, et al. Improved management of invasive aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139-147.
53. Bretagne S, Costa JM, Marmorat-Khuong A, et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol 1995; 33: 1164-1168.
54. Melchers WJ, Verweij PE, van der Hurk P, et al. General primer - mediated PCR for detection of Aspergillus species. J Clin Microbiol 1994; 32: 1710-1717.
55. Einsele H, Hebart H, Roller G, et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35: 1353-1360.
56. Van Burik JA, Myerson D, Schrechise RW, Bowden RA. Panfungal PCR assay for detection of fungal infection in human blood specimens. J Clin Microbiol 1998; 36: 1169-1175.
57. Kawazu M, Kanda Y, Goyama S, et al. Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid. Am J Hematol. 2003;72:27-30.
58. Sanguinetti M, Posteraro B, Pagano L, et al. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2003;41:3922-3925.
59. Löffler J, Hebart H, Brauchle V, Schumacher V, Einsele H. Comparison between plasma and whole blood specimens for detection of Aspergillus DNA by PCR. J Clin Microbiol 2000; 38: 3830-3833.
60. Herbart H, Löffler J, Meisner C, et al. Early detection of Aspergillus infection after allogenic stem cell transplantation by plymerase chain reaction screening. J Infect Dis 2000; 181: 1713-1719.
61. Loeffler J, Kloepfer K, Hebart H, Najvar L, Graybill JR, Kirkpatrick WR, Patterson TF, Dietz K, Bialek R, Einsele H. Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis. J Infect Dis. 2002;185: 1203-1206.
62. Loeffler J, Henke N, Hebart H, et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J Clin Microbiol 2000; 38: 586-590.
63. Kami M, Fukui T, Ogawa S, et al. Use of real time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001; 33: 1504-1512.
64. Spiess B, Buchheidt D, Baust C, et al. Development of a Light Cycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol 2003; 41: 1811-1818.
65. Costa C, Costa JM, Desterke C, et al. Real time PCR conpled with automated DNA extraction and detection of antigen in serum by Enzyme-Linked Immunosorbent assay for the diagnosis of invasive aspergillosis. J Clin Microbiol 2002; 40: 2224-2227.